News

Viking Therapeutics Set for Multiple Investor Conference Appearances

Viking Therapeutics Set for Multiple Investor Conference Appearances

Viking Therapeutics Set for Multiple Investor Conference Appearances

Viking Therapeutics, Inc. (NASDAQ: VKTX) is excited to share that it will participate in several upcoming investor conferences aimed at highlighting its advancements in biopharmaceutical development. As a clinical-stage company, Viking focuses on innovative therapies for metabolic and endocrine disorders. Upcoming events present a unique opportunity for the company to engage with potential investors and discuss its promising drug developments, innovations, and the transformative potential of its therapies.

Details of Upcoming Conferences

Here are the key details regarding Viking's participation in the upcoming conferences:

William Blair 45th Annual Growth Stock Conference

At this conference, Viking's management will deliver a comprehensive corporate presentation and engage in a fireside chat along with one-on-one meetings.

  • Conference Dates: June 3-5
  • Presentation Timing: 2:00 – 2:30 p.m. Central on Tuesday, June 3
  • Location: Chicago

Jefferies Global Healthcare Conference

This conference will feature another presentation by Viking management, followed by one-on-one meetings with interested investors.

  • Conference Dates: June 3-5
  • Presentation Timing: 11:40 a.m. – 12:10 p.m. Central on Thursday, June 5
  • Location: New York, in addition to a webcast available for online attendees

46th Annual Goldman Sachs Global Healthcare Conference

During this prestigious conference, Viking management will participate in one-on-one discussions with investors to detail the company's progress and strategic direction.

  • Conference Dates: June 9-11
  • Location: Miami

Scotiabank Third Annual Healthcare Canadian Investor Day

Viking will again engage with investors through one-on-one meetings during this event, solidifying its commitment to transparency and investor relations.

  • Conference Date: June 17
  • Location: Toronto, Canada

Webcasts and Conference Access

Viking Therapeutics will also provide live access to the Jefferies conference presentations, allowing broader participation from interested stakeholders. Details regarding accessing the live webcast can be found on Viking's official website in the Investors & Media section. A replay of the presentation will be accessible afterward for those unable to attend live.

About Viking Therapeutics, Inc.

Viking is committed to revolutionizing the treatment landscape for metabolic and endocrine disorders through its robust pipeline. The company is actively developing several therapies, including VK2735, an innovative dual agonist targeting GLP-1 and GIP receptors. This therapy shows great promise in clinical trials for various metabolic disorders, demonstrating a favorable safety profile and potential clinical benefits.

Further, Viking continues to advance VK2809, designed to treat lipid and metabolic disorders, which has successfully met key endpoints in recent studies. As part of its research efforts, the company is also examining a series of dual amylin and calcitonin receptor agonists for the treatment of obesity. Finally, VK0214 is being developed for X-linked adrenoleukodystrophy (X-ALD), proving to be safe and effective in early clinical trials.

For more insights about Viking Therapeutics, please visit www.vikingtherapeutics.com.

Frequently Asked Questions

What is Viking Therapeutics known for?

Viking Therapeutics specializes in the development of innovative therapies for metabolic and endocrine disorders.

What conferences will Viking participate in?

Viking is participating in the William Blair, Jefferies, Goldman Sachs, and Scotiabank conferences, among others.

When will Viking present at the Jefferies conference?

Viking's presentation at the Jefferies Global Healthcare Conference is scheduled for June 5.

What are VK2735 and VK2809?

VK2735 is a dual agonist for metabolic disorders, while VK2809 is targeted for lipid and metabolic disorders. Both are in various stages of clinical trials.

How can I access the conference presentations?

Live webcasts of the conferences will be available on Viking's website, along with replays after the events conclude.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 179

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 106

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 137

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 74

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 106

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 150

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 95

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 143

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading

Top 5 Most Recently Viewed Articles

Berry Global Plans Senior Secured Notes Offering Ahead of Merger

Updated Category News Views 126

Berry Global’s Strategic Offering of Senior Secured Notes In an exciting development, Berry Global Group, Inc. (NYSE:BERY) has outlined plans for the issuance of senior secured notes through its subsidiary, Treasure Escrow Corporation. This move is a crucial step in conjunction with the anticipated merger of Berry's Health, Hygiene and Specialties Global Nonwovens and...

Continue Reading
Hexaware Technologies Expands Presence with New London HQ

Updated Category News Views 260

Hexaware Technologies Expands Its Footprint with New Headquarters Hexaware Technologies, a renowned name in the realm of IT, AI, and digital services, has recently taken a significant step by inaugurating its new UK headquarters at One Canada Square, in the vibrant Canary Wharf area. This new facility is set to play a crucial role in the company’s strategy to enhance...

Continue Reading
Aroa Biosurgery Advances in Treating Venous Leg Ulcers

Updated Category News Views 343

Aroa Biosurgery Advances in Treating Venous Leg Ulcers Aroa Biosurgery, a leading name in soft tissue regeneration technology, has achieved a significant milestone in clinical evidence for their proprietary Endoform product. The company announced that over 100 peer-reviewed studies now confirm the efficacy of their AROA ECM technology in treating various wound types....

Continue Reading
Innovative Paver Spacer Designed for Perfect Alignment

Updated Category News Views 231

Revolutionizing Landscape Design with a New Paver Spacer The landscape industry is continuously evolving, and one of the most exciting innovations to recently emerge is a specialized paver spacer. This unique design addresses a common problem faced by landscapers and homeowners alike: the challenge of aligning concrete or clay pavers effectively. An inventor with a vision...

Continue Reading
Transforming Diagnostics: The Rise of Digital Pathology Market

Updated Category News Views 232

Understanding Digital Pathology Market Dynamics In recent years, the Digital Pathology Market has emerged as a key player in the healthcare sector, showing significant growth and innovation. With an expected market size of USD 2.92 billion by the end of the forecast period, the sector has captured investor interest and demonstrated the potential to reshape diagnostic...

Continue Reading